Vivanza Biosciences Q2 Results
- BSE: 530057
- NSE: -
- ISIN: INE984E01035
- Sector: Biotechnology & Drugs
BSE
2.15
0.06 (2.87%)
0.06 (2.87%)Volume87.31 K
Updated: Fri 20 Jun, 2025 | 15:21:04
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Vivanza Biosciences Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 24 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 3.00 | 2.44 | 23.02% | 3.00 | N/A |
| Selling/ General/ Admin Expenses Total | 0.14 | 0.15 | -10.03% | 0.14 | N/A |
| Depreciation/ Amortization | 0.00 | 0.00 | 36.67% | 0.00 | N/A |
| Other Operating Expenses Total | 0.04 | 0.10 | -61.66% | 0.04 | N/A |
| Total Operating Expense | 2.90 | 2.08 | 38.96% | 2.90 | N/A |
| Operating Income | 0.11 | 0.36 | -70.44% | 0.11 | N/A |
| Net Income Before Taxes | 0.02 | 0.27 | -94.17% | 0.02 | N/A |
| Net Income | 0.02 | 0.27 | -94.17% | 0.02 | N/A |
| Diluted Normalized EPS | 0.00 | 0.07 | -94.46% | 0.00 | N/A |